Status:
COMPLETED
Le Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South Africa
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
TB HIV Care
Conditions:
Pre-exposure Prophylaxis
HIV Infections
Eligibility:
FEMALE
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact of a social media campaign and community engagement activities to promote pre-exposure prophylaxis (PrEP) use among young women and to influence com...
Detailed Description
The cluster randomized trial (CRT) will not engage in PrEP provision to individuals, but instead employs geographical regions to serve as units of randomization where social media content and communit...
Eligibility Criteria
Inclusion
- Eligible to take PrEP per TB HIV Care programmatic criteria
- Engaged in TB HIV Care HIV prevention program
Exclusion
- Not eligible for PrEP (not at risk for HIV) per TB HIV Care programmatic criteria
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
601 Patients enrolled
Trial Details
Trial ID
NCT05417620
Start Date
October 1 2022
End Date
November 20 2023
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TB HIV Care
Cape Town, Western Cape, South Africa